An estimated 100 million adult Americans— more than 40 percent of the population —are classified as obese. This is a massive health crisis that will claim many lives over the next decades. As is well known, drugs now exist that can dramatically reduce obesity and its related health risks. But most of the roughly 37 million adult Americans on Medicaid—an estimated 14 million of whom suffer from obesity—do not have access to these drugs, known as GLP-1s. The reason is simple: These medications